SCHEMBL5281472

SCHEMBL5281472

O=C(OCCNCCc1ccccc1)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.37
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
KDM4E B2RXH2 5/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CHRNB2 P17787 4/20 0.34
CHRNB4 P30926 4/20 0.34
CHRNA3 P32297 4/20 0.34
CHRNA4 P43681 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5247685 0.85 OPRK1 (0.37) CHRM1
SCHEMBL6027383 0.84 OPRM1 (0.36) KDM4EMEN1KMT2AALDH1A1
SCHEMBL6027738 0.83 ESRRG (0.40) GAASMN1; SMN2
SCHEMBL6027362 0.83 TRPV1 (0.39) ALDH1A1
SCHEMBL6028196 0.82 ITGB1 (0.33) SMN1; SMN2ALDH1A1
SCHEMBL5722184 0.82 CHRM5 (0.38) SMN1; SMN2MEN1KMT2ACHRNB2CHRNB4
SCHEMBL4695511 0.81 PDCD1 (0.34) HTTSMN1; SMN2
SCHEMBL4695551 0.81 CNR2 (0.40) GAASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL4691773 0.81 KDM4E (0.41) KDM4EMEN1KMT2AALDH1A1
SCHEMBL6022221 0.81 BCHE (0.39) L3MBTL1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866284-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2007-12-19 EP disclosed
WO-2006099167-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-09-21 WO disclosed